Close
Achema middle east

Yuvraj

Micell Technologies Announces Expanded Patent Estate

Micell® Technologies, Inc., a privately-held, development-stage biomedical company, today provided an update on its recently expanded intellectual property portfolio. With the granting of 24...

Invictus Opens TSX Venture Exchange Trading as GENE for the First Time

INVICTUS MD STRATEGIES CORP. is pleased to announce that , Gene Simmons, Chief Evangelist Officer for the company and its management team opened the...

Lundbeck pharma acquires Prexton Therapeutics in EUR905m deal

Danish pharma company H. Lundbeck has agreed to acquire Switzerland-based Prexton Therapeutics, which develops drugs for Parkinson's disease and other brain disorders, in a...

Pradaxa®’s Favourable safety profile (dabigatran etexilate) confirmed in large prospective real-world analysis

New data from one of the largest prospective ongoing global studies examining the use of oral antithrombotics for stroke prevention in atrial fibrillation (AF)...

Sandoz globally collaborates with Biocon on next generation biosimilars

Sandoz, a Novartis division and the global leader in biosimilars, announced a global partnership with Asia's premier biopharmaceuticals company, Biocon, to develop, manufacture and...

Cobra Biologics and Symbiosis awarded £1.9m ($2.5m USD) Innovate UK Grant

Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, and Symbiosis Pharmaceutical Services (Symbiosis), a contract manufacturing organisation...

UPM Raflatac’s insightful pharmaceutical and healtcare labeling at Pharmapack 2018

UPM Raflatac's pharmaceutical and healthcare labeling experts will be present at Pharmapack exhibition on 7-8 February 2018 in Paris, France. Visitors...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »